Nvidia is turning its AI firepower toward the hardest problems in medicine, striking multibillion-dollar alliances with ...

SOUTH SAN FRANCISCO, Calif. (KGO) -- As the demand for new drugs is growing, it's challenging the biotech industry to re-think its approach to making them for clinical trials. South San Francisco's ...

After its founding in 1976, scientists at Genentech worked methodically toward the development of its first biotechnology product. It was nearly a decade later that the FDA approved Protropin, a ...